Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations

Find Full text
Publication year
2009
Author(s)
Luin, M. van
Gras, L.
Richter, C.
Ende, M.E. van der
Prins, J.M.
Wolf, F. de
Burger, D.M.
Wit, F.W.
Source
JAIDS : Journal of Acquired Immune Deficiency Syndromes, 52, 2, (2009), pp. 240-245
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/80841   https://hdl.handle.net/2066/80841
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.